Evaluating repetitive ¹⁸F-fluoroazomycin-arabinoside (¹⁸FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer

References

• Nordsmark M, Overgaard J. Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer. Acta Oncol 2004;43:396–403.
   PubMed Web of Science ®Google Scholar
• Fyles A, Milosevic M, Hedley D, Pintilie M, Levin W, Manchul L, . Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 2002;20:680–7.
   PubMed Web of Science ®Google Scholar
• Rasey JS, Koh WJ, Grierson JR, Grunbaum Z, Krohn KA. Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia. Int J Radiat Oncol Biol Phys 1989;17:985–91.
   PubMed Web of Science ®Google Scholar
• Rasey JS, Grunbaum Z, Magee S, Nelson NJ, Olive PL, Durand RE, . Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells. Radiat Res 1987; 111:292–304.
   PubMed Web of Science ®Google Scholar
• Reischl G, Dorow DS, Cullinane C, Katsifis A, Roselt P, Binns D, . Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA–first small animal PET results. J Pharm Pharm Sci 2007;10:203–11.
   PubMed Web of Science ®Google Scholar
• Sorger D, Patt M, Kumar P, Wiebe LI, Barthel H, Seese A, . [18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): A comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors. Nucl Med Biol 2003;30:317–26.
   PubMed Web of Science ®Google Scholar
• Souvatzoglou M, Grosu AL, Roper B, Krause BJ, Beck R, Reischl G, . Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: A pilot study. Eur J Nucl Med Mol Imaging 2007;34:1566–75.
   PubMed Web of Science ®Google Scholar
• Busk M, Horsman MR, Jakobsen S, Hansen KV, Bussink J, van der Kogel A, . Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast? Radiother Oncol 2009;92:429–36.
   PubMed Web of Science ®Google Scholar
• Potter R, Fidarova E, Kirisits C, Dimopoulos J. Image-guided adaptive brachytherapy for cervix carcinoma. Clin Oncol (R Coll Radiol) 2008;20:426–32.
   PubMed Web of Science ®Google Scholar
• Potter R, Dimopoulos J, Georg P, Lang S, Waldhausl C, Wachter-Gerstner N, . Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007;83: 148–55.
   PubMed Web of Science ®Google Scholar
• Dimopoulos JC, Kirisits C, Petric P, Georg P, Lang S, Berger D, . The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys 2006; 66:83–90.
   PubMed Web of Science ®Google Scholar
• Dimopoulos JC, Potter R, Lang S, Fidarova E, Georg P, Dorr W, . Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy. Radiother Oncol 2009;93:311–5.
   PubMed Web of Science ®Google Scholar
• Kumar P, Stypinski D, Xia H, McEwan AJ, Machulla HJ, Wiebe LI. Fluoroazomycin arabinoside (FAZA): synthesis, 2H and 3H-labelling and preliminary biological evaluation of a novel 2-nitromidazole marker of tissue hypoxia. J Label Compd Radiopharm 1999;42:3–16.
   Web of Science ®Google Scholar
• Hicks RJ, Rischin D, Fisher R, Binns D, Scott AM, Peters LJ. Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent. Eur J Nucl Med Mol Imaging 2005;32: 1384–91.
   PubMed Web of Science ®Google Scholar
• Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, . Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 2005;77: 18–24.
   PubMed Web of Science ®Google Scholar
• Hockel M, Knoop C, Schlenger K, Vorndran B, Baussmann E, Mitze M, . Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993;26:45–50.
   PubMed Web of Science ®Google Scholar
• Fyles AW, Milosevic M, Wong R, Kavanagh MC, Pintilie M, Sun A, . Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 1998;48: 149–56.
   PubMed Web of Science ®Google Scholar
• Knocke TH, Weitmann HD, Feldmann HJ, Selzer E, Potter R. Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix. Radiother Oncol 1999;53:99–104.
   PubMed Web of Science ®Google Scholar
• Hockel M, Schlenger K, Knoop C, Vaupel P. Oxygenation of carcinomas of the uterine cervix: Evaluation by computerized O2 tension measurements. Cancer Res 1991;51: 6098–102.
   PubMed Web of Science ®Google Scholar
• Vaupel P, Schlenger K, Knoop C, Hockel M. Oxygenation of human tumors: Evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res 1991;51:3316–22.
   PubMed Web of Science ®Google Scholar
• Dimopoulos JC, Lang S, Kirisits C, Fidarova EF, Berger D, Georg P, . Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 2009;75: 56–63.
   PubMed Web of Science ®Google Scholar
• Tanderup K, Georg D, Potter R, Kirisits C, Grau C, Lindegaard JC. Adaptive management of cervical cancer radiotherapy. Semin Radiat Oncol 2010;20:121–9.
   PubMed Web of Science ®Google Scholar
• Mayr NA, Wang JZ, Zhang D, Montebello JF, Grecula JC, Lo SS, . Synergistic effects of hemoglobin and tumor perfusion on tumor control and survival in cervical cancer. Int J Radiat Oncol Biol Phys 2009;74:1513–21.
   PubMed Web of Science ®Google Scholar
• Mayr NA, Taoka T, Yuh WT, Denning LM, Zhen WK, Paulino AC, . Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2002;52:14–22.
   PubMed Web of Science ®Google Scholar
• Rischin D, Hicks RJ, Fisher R, Binns D, Corry J, Porceddu S, . Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: A substudy of Trans-Tasman Radiation Oncology Group Study 98.02. J Clin Oncol 2006;24:2098–104.
   PubMed Web of Science ®Google Scholar